background image

Follicular Lymphoma Clinical Trials

Find clinical trials for follicular lymphoma. Search for follicular lymphoma clinical trials in different cities and states across the United States.

Filter
1

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

for
Diffuse Large B-Cell Lymphoma,
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT03147885

Phase1, Phase2, Recruiting

Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma

for
Ann Arbor Stage II Follicular Lymphoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06442475

Phase2, Recruiting

64Cu-LLP2A for Imaging Hematologic Malignancies

for
Multiple Myeloma, Low-Grade Lymphoma, Follicular Lymphoma,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06636175

Early_phase1, Recruiting

IKS03 in Patients with Advanced B Cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma,
Location: Baltimore MD, Montréal
Sponsor: Iksuda Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT05365659

Phase1, Recruiting

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

for
Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL),
Location: Duarte CA, Chicago IL, Rochester MN, Omaha NE, Portland OR,
Sponsor: MEI Pharma, Inc.

Sex: All

Age: 18+

Code: NCT03547115

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Duarte CA, Denver CO, Chicago IL, Bethesda MD, Nashville TN,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase1, Recruiting

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

for
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04883437

Phase2, Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

for
Follicular Lymphoma, Mantle Cell Lymphoma, Hairy Cell Leukemia,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06340737

Phase1, Recruiting

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

for
Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma
Location: Sacramento CA
Sponsor: Joseph Tuscano

Sex: All

Age: 18+

Code: NCT04587687

Phase2, Recruiting

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

for
Follicular Lymphoma, Marginal Zone Lymphoma, B-Cell Lymphoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06350318

Phase2, Recruiting